Proteome Sciences plc provided revenue guidance for 2013. For the year, revenue expected to show a significant increase over 2012 resulting from the strong performance across core activities.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.185 GBX | +0.60% | +8.42% | -7.62% |
16/05 | Proteome Sciences promises AGM return to growth in 2024 | AN |
16/05 | AIM WINNERS & LOSERS: Proteome Sciences eyes return to growth in 2024 | AN |
1st Jan change | Capi. | |
---|---|---|
-7.62% | 1.57Cr | |
-5.18% | 18TCr | |
+0.19% | 11TCr | |
-2.40% | 6.83TCr | |
-6.95% | 4.7TCr | |
+13.87% | 4.56TCr | |
+7.77% | 4.24TCr | |
+19.41% | 3.1TCr | |
+16.55% | 2.55TCr | |
-7.12% | 2.32TCr |
- Stock Market
- Equities
- PRM Stock
- News Proteome Sciences plc
- Proteome Sciences plc Provides Revenue Guidance for 2013